awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38694947-3E42165A-3915-4664-8C5A-E6A0D579F558
Q38694947-3E42165A-3915-4664-8C5A-E6A0D579F558
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38694947-3E42165A-3915-4664-8C5A-E6A0D579F558
On the pharmacogenetics of non-small cell lung cancer treatment.
P2860
Q38694947-3E42165A-3915-4664-8C5A-E6A0D579F558
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38694947-3E42165A-3915-4664-8C5A-E6A0D579F558
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
508cb8f6fa8c751aceba993070554b346112a45d
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.